MedPath

Role of Tila taila katibasti and pinda sweda of erand in management of Grudrasi i.eSciatica

Not yet recruiting
Conditions
Nerve root and plexus compressionsin diseases classified elsewhere. Ayurveda Condition: GRUDHRASI,
Registration Number
CTRI/2021/05/033654
Lead Sponsor
Sane Guruji Arogya Kendra
Brief Summary

This is a clinical study to evaluate the efficacy of TILA TAILA KTIBASTI WITH ERANDA PATRA PINDA SWEDA AND TILA TAILA KATIBASTI IN GRIDHRASI.The primary objective of sudy is to compare efficacy of TILA TAILA KATIBASTI WITH ERANDA PATRA PINDA SWEDA AND TILA TAILA KATIBASTI IN GRIDHRASI. TILA TAILA KATIBASTI will be given to both group of patients with GRIDHRASI. One group of GRIDHRASI patients will be treated with TILA TAILA KATIBASTI with ERANDA PATRA PINDA SWEDA for 7 days. Second group of GRIDHRASI patients will be treated with only TILA TAILA KATIBASTI for 7 days. Observation will be drawn from outcome of treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients presenting with classical Sign and Symptoms of Gridhrasi.
  • Snehan Arha.
  • Swedan Arha.
Exclusion Criteria
  • Fracture Conditions.
  • Any other systemic Conditions which may interfere the treatment – K/C/O- TB, CA.
  • Rheumatoid Arthritis.
  • Pregnant Women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the effect of combination of Tila Taila Katibasti and Erandapatra Pinda Sweda with only Tila Taila Katibasti once in a day for seven days in the management of Gridhrasi.TREATMENT WILL BE GIVEN FOR 7 DAYS. PATIENTS WILL BE ASSESSED ON 1, 3, 7 TH DAY.
Secondary Outcome Measures
NameTimeMethod
To assess the effect of Tila Tila Katibasti with Eranda Patra PindaSweda in Gridhrasi.

Trial Locations

Locations (1)

Sane Guruji Arogya Kendra

🇮🇳

Pune, MAHARASHTRA, India

Sane Guruji Arogya Kendra
🇮🇳Pune, MAHARASHTRA, India
DR Ruchita Gurudas Pal
Principal investigator
9834367303
ruchitapal2022@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.